Eli Lilly gets FDA approval for new drug to slow Alzheimer's

  Рет қаралды 670

BNN Bloomberg

BNN Bloomberg

8 күн бұрын

Neela White, senior portfolio manager at Blue Wing Advisory Group, Raymond James, joins BNN Bloomberg to discuss Q2 earnings growth expectations and Eli Lilly's latest endeavor.
Subscribe to BNN Bloomberg to watch more videos: / bnnbloomberg
Connect with BNN Bloomberg:
For the latest news visit: www.bnnbloomberg.ca
For a full video offering visit BNN Bloomberg: www.bnnbloomberg.ca/video
BNN Bloomberg on Facebook: / bnnbloomberg
BNN Bloomberg on Twitter: / bnnbloomberg
BNN Bloomberg on Instagram: / bnnbloomberg
BNN Bloomberg on LinkedIn: / bnn-bloomberg
--
BNN Bloomberg is Canada’s only TV service devoted exclusively to business, finance and the markets.

Пікірлер: 2
@Michael-pg7rv
@Michael-pg7rv 6 күн бұрын
Sickening that this drug will cost patients in the US $32K for a year.
Canada's long-term economic outlook
9:14
BNN Bloomberg
Рет қаралды 17 М.
Expert sheds light on new drug to treat Alzheimer's disease
3:34
Survival skills: A great idea with duct tape #survival #lifehacks #camping
00:27
I Can't Believe We Did This...
00:38
Stokes Twins
Рет қаралды 90 МЛН
Saskatchewan has squandered its potash wealth: Cline
7:14
BNN Bloomberg
Рет қаралды 6 М.
Poll: How higher living costs impact desires to live in Canada
5:56
Why are so many big-city condos sitting empty? | About That
12:19
Hudson's Bay Company to buy Neiman Marcus
6:26
BNN Bloomberg
Рет қаралды 6 М.
How a New Type of Immigration Is Radically Changing Portugal’s Economy
11:00
Economics Explained
Рет қаралды 614 М.
Survival skills: A great idea with duct tape #survival #lifehacks #camping
00:27